These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 22351245)

  • 1. MRI findings of inflammatory breast cancer, locally advanced breast cancer, and acute mastitis: T2-weighted images can increase the specificity of inflammatory breast cancer.
    Uematsu T
    Breast Cancer; 2012 Oct; 19(4):289-94. PubMed ID: 22351245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
    Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
    Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory breast carcinoma in magnetic resonance imaging: a comparison with locally advanced breast cancer.
    Renz DM; Baltzer PA; Böttcher J; Thaher F; Gajda M; Camara O; Runnebaum IB; Kaiser WA
    Acad Radiol; 2008 Feb; 15(2):209-21. PubMed ID: 18206620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic aspects of inflammatory breast carcinoma: part 1. Histomorphology and differential diagnosis.
    Resetkova E
    Semin Oncol; 2008 Feb; 35(1):25-32. PubMed ID: 18308143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report of bilateral inflammatory breast cancer.
    Masannat YA; Peter M; Turton P; Shaaban AM
    Eur J Cancer Care (Engl); 2010 Jul; 19(4):558-60. PubMed ID: 19708943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory breast cancer: challenges and developments.
    Ferrara AR
    Radiol Technol; 2008 Sep; 80(1):49M-60M; quiz 61M-63M. PubMed ID: 18796566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin thickening as unique pathologic sign of an inflammatory breast cancer: a case report and review of the literature.
    Ballesio L; D'Ambrosio I; Ravazzolo N; Angeletti M; Di Pastena F; Tardioli S; Lodise P; Marini M
    Clin Ter; 2011; 162(4):351-4. PubMed ID: 21912823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can T2-weighted 3-T breast MRI predict clinically occult inflammatory breast cancer before pathological examination? A single-center experience.
    Uematsu T; Kasami M; Watanabe J
    Breast Cancer; 2014 Jan; 21(1):115-21. PubMed ID: 23104394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging features of inflammatory breast metastasis from gastric signet-ring cell carcinoma.
    Kim SJ
    Clin Imaging; 2013; 37(3):569-73. PubMed ID: 23068056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons learned from an unusual case of inflammatory breast cancer.
    Harrison AM; Zendejas B; Ali SM; Scow JS; Farley DR
    J Surg Educ; 2012; 69(3):350-4. PubMed ID: 22483137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study.
    Renz DM; Baltzer PA; Böttcher J; Thaher F; Gajda M; Camara O; Runnebaum IB; Kaiser WA
    Eur Radiol; 2008 Nov; 18(11):2370-80. PubMed ID: 18523781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating inflammatory breast cancer from acute mastitis.
    Dahlbeck SW; Donnelly JF; Theriault RL
    Am Fam Physician; 1995 Sep; 52(3):929-34. PubMed ID: 7653430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor lymphangiogenesis in inflammatory breast carcinoma: a histomorphometric study.
    Van der Auwera I; Van den Eynden GG; Colpaert CG; Van Laere SJ; van Dam P; Van Marck EA; Dirix LY; Vermeulen PB
    Clin Cancer Res; 2005 Nov; 11(21):7637-42. PubMed ID: 16278382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted magnetic resonance imaging in the characterization of axillary lymph nodes in patients with breast cancer.
    Fornasa F; Nesoti MV; Bovo C; Bonavina MG
    J Magn Reson Imaging; 2012 Oct; 36(4):858-64. PubMed ID: 22648570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin B: a potential prognostic marker for inflammatory breast cancer.
    Nouh MA; Mohamed MM; El-Shinawi M; Shaalan MA; Cavallo-Medved D; Khaled HM; Sloane BF
    J Transl Med; 2011 Jan; 9():1. PubMed ID: 21199580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous bilateral breast and high-resolution axillary MRI of patients with breast cancer: preliminary results.
    Luciani A; Dao TH; Lapeyre M; Schwarzinger M; Debaecque C; Lantieri L; Revelon G; Bouanane M; Kobeiter H; Rahmouni A
    AJR Am J Roentgenol; 2004 Apr; 182(4):1059-67. PubMed ID: 15039188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving role of imaging modalities in inflammatory breast cancer.
    Le-Petross CH; Bidaut L; Yang WT
    Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential MRI interpretation model: differentiation of benign from malignant breast masses.
    Malich A; Fischer DR; Wurdinger S; Boettcher J; Marx C; Facius M; Kaiser WA
    AJR Am J Roentgenol; 2005 Oct; 185(4):964-70. PubMed ID: 16177416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrimination of axillary metastatic from nonmetastatic lymph nodes with PROPELLER diffusion-weighted MR imaging in a metastatic breast cancer model and its correlation with cellularity.
    Junping W; Tongguo S; Yunting Z; Chunshui Y; Renju B
    J Magn Reson Imaging; 2012 Sep; 36(3):624-31. PubMed ID: 22570219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculous adenopathy masquerading as locally advanced breast cancer.
    Walsh N; Greene J; Catherine Lee M
    Breast J; 2013; 19(1):106-7. PubMed ID: 23279334
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.